London And Göttingen

LONDON and GTTINGEN, Germany, January 12 - Reference MRCT: MRCT120110 Georg-August-University Gttingen, University of Regensburg and MRC Technology (MRCT) have signed exclusive license agreements through MBM ScienceBridge GmbH and in agreement with Bayerische Patentallianz GmbH, for the development of a novel therapy of inflammatory and immune diseases based on the depletion of inflammatory monocytes.